Phenylalanine and tyrosine metabolism in chronic kidney failure

Journal of Nutrition

Volumn 137, Issue 6, 2007, Pages

  Kopple, Joel D ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; PHENYLALANINE; TYROSINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIETARY INTAKE; HUMAN; HYDROXYLATION; KIDNEY TUBULE ABSORPTION; NONHUMAN; OXIDATIVE STRESS; URINARY EXCRETION;

ANIMALIA;

EID: 34249776692     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.6.1586s     Document Type: Conference Paper

References (48)

1. Harper AE. Phenylalanine metabolism. In: Stegink LD, Filer LJ, editors. Aspartame physiology and biochemistry. New York: Marcel Dekker; 1984. pp 77-109.
2. Kopple JD, Bernard D, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Brunori G, Leiserowitz M, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47:1148-57.
3. Chazot C, Shahmir E, Matias B, Laidlaw S, Kopple JD. Dialytic nutrition: provision of amino acids in dialysate during Hemodialysis. Kidney Int. 1997;52:1663-70.
4. Giordano C, De Pascale C, De Cristofare D, Capodicasa G, Balestrieri C, Baczyk K. Protein malnutrition in the treatment of chronic uremia. In: Berlyne CM, editor. Nutrition in renal disease. Edinburgh: Livingstone; 1967. p. 23-34.
5. Gulyassy PF, Aviram A, Peters JH. Evaluation of amino acid and protein requirements in chronic uremia. Arch Intern Med. 1970;126:855-9.
6. Kopple JD, Wang M, Vyhmeister I, Baker N, Swendseid ME. Tyrosine metabolism in uremia: an international conference on pathogenesis, diagnosis and therapy. In: Uremia, Kluthe R, Berlyne C, Burton B, editors. Stuttgart: Georg Thieme Verlag; 1972. p. 150-63.
7. Bergstrom J, Furst P, Noree LO, Vinnars E. The effect of peritoneal dialysis on intracellular free amino acids in muscle from uraemic patients. Proc Eur Dial Transplant Assoc. 1972;9:393-401.
8. Young GA, Parsons FM. Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clin Sci. 1973;45:89-97.
9. Wang M, Vyhmeister I, Swendseid ME, Kopple JD. Phenylalanine hydroxylase and tyrosine aminotransferase activities in chronically uremic rats. J Nutr. 1975;105:122-7.
10. Jones MR, Kopple JD, Swendseid ME. Phenylalanine metabolism in uremic and normal man. Kidney Int. 1978;14:169-79.
11. Fukuda S, Kopple JD. Chronic uremia syndrome in dogs induced with uranyl nitrate. Nephron. 1980;25:139-43.
12. Furst P, Alvesstrand A, Bergstrom J. Effects of nutrition and catabolic stress on intracellular amino acid pools in uremia. Am J Clin Nutr. 1980;33:1387-95.
13. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr. 1982;36:395-402.
14. Flugel-Link RM, Jones MR, Kopple JD. Red cell and plasma amino acid concentrations in renal failure. JPEN J Parenter Enteral Nutr. 1983;7:450-6.
15. Laidlaw SA, Berg RL, Kopple JD, Naito H, Walker WG, Walser M. Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1994;23:504-13.
16. Tourian A, Goddard J, Puck TT. Phenylalanine hydroxylase activity in mammalian cells. J Cell Physiol. 1969;73:159-70.
17. Fukuda S, Kopple JD. Uptake and release of amino acids by the normal dog kidney. Miner Electrolyte Metab. 1980;3:237-47.
18. Kopple JD, Fukuda S. Effects of amino acid infusion and renal failure on the uptake and release of amino acids by the dog kidney. Am J Clin Nutr. 1980;33:1363-72.
19. Fukuda S, Kopple JD. Uptake and release of amino acids by the kidney of dogs made chronically uremic with uranyl nitrate. Miner Electrolyte Metab. 1980;3:248-60.
20. Garibotto G, Deferrari G, Robaudo C, Saffioti S, Salvidio G, Paoletti E, Tizianello A. Effect of amino acid ingestion on blood amino acid profile in patients with chronic renal failure. Am J Clin Nutr. 1987;46:949-54.
21. Garibotto G, Deferrari G, Robaudo C, Saffioti S, Paoletti E, Pontremoli R, Tizianello A. Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. Nephron. 1993;64:216-25.
22. Druml W, Kleinberger G, Burger U, Balcke P, Laggner A, Lenz K, Schmidt P, Zazgornik J. Elimination of amino acids in chronic renal failure. Infusionsther Klin Ernahr. 1986;13:262-7.
23. Druml W, Roth E, Lenz K, Lochs H, Kopsa H. Phenylalanine and tyrosine metabolism in renal failure: dipeptides as tyrosine source. Kidney Int Suppl. 1989;27:S282-6.
24. Tizianello A, De Ferrari G, Garibotto G, Robaudo C. Amino acid metabolism and the liver in renal failure. Am J Clin Nutr. 1980;33:1354-62.
25. Deferrari G, Garibotto G, Robaudo C, Sala M, Tizianello A. Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency. Am J Clin Nutr. 1988;48:72-83.
26. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest. 1980;65:1162-73.
27. Brundin T, Wahren J. Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man. Am J Physiol. 1994;267:E648-55.
28. Tessari P, Garibotto G, Inchiostro S, Robaudo C, Saffioti S, Vettore M, Zanetti M, Russo R, Deferrari G. Kidney, splanchnic, and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics. J Clin Invest. 1996;98:1481-92.
29. Tessari P, Deferrari G, Robaudo C, Vettore M, Pastorino N, De Biasi L, Garibotto G. Phenylalanine hydroxylation across the kidney in humans. Kidney Int. 1999;56:2168-72.
30. Moller N, Meek S, Bigelow M, Andrews J, Nair KS. The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: a metabolic role of the kidney. Proc Natl Acad Sci USA. 2000;97:1242-6.
31. Garibotto G, Deferrari G, Robaudo C, Saffioti S, Sofia A, Russo R, Tizianello A. Disposal of exogenous amino acids by muscle in patients with chronic renal failure. Am J Clin Nutr. 1995;62:136-42.
32. Garibotto G, Tessari P, Verzola D, Dertenois L. The metabolic conversion of phenylalanine into tyrosine in the human kidney: does it have nutritional implications in renal patients? J Ren Nutr. 2002;12:8-16.
33. Boirie Y, Albright R, Bigelow M, Nair KS. Impairment of phenylalanine conversion to tyrosine in end-stage renal disease causing tyrosine deficiency. Kidney Int. 2004;66:591-6.
34. Diem K, Lentner C, editors. Scientific Tables. Documenta Geigy. 7th ed. Basle: Ciba-Geigy Limited; 1970. p. 667.
35. Daphnis E, Houseal LM, Sabatini S. Isolated renal tubular disorders: molecular mechanism and clinical expression of disease. In: Schrier RW, editor. Diseases of the kidney and urinary tract. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p 621-46.
36. Lindheimer MD, Kata AI. The normal and diseased kidney pregnancy. In: Schrier RD, editor. Diseases of the kidney and urinary tract. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2129-65.
37. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int. 1994;46:830-7.
38. Giordano C, DeSanto NG, Capodicasa G, DiLeo VA, DiSerafino A, Cirillo D, Esposito R, Fiore R, Damiano M, et al. Amino acid losses during CAPD. Clin Nephrol. 1980;14:230-2.
39. Kopple JD, Swendseid ME, Shinaberger JH, Umezawa CY. The free and bound amino acids removed by hemodialysis. Trans Am Soc Artif Intern Organs. 1973;19:309-13.
40. Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int. 1982;21:500-6.
41. Himmelfarb J, McMenamin ME, Loseto G, Heinecke W. Myeloperoxidasecatalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med. 2001;31:1163-9.
42. Horl WH. Oxidant stress. In: Kopple JD, Massry SG, editors. Nutritional management of renal disease. 2nd ed. Baltimore: Lippincott Williams and Wilkins; 2004. p. 99-110.
43. Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MM. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int. 2000;57:1968-72.
44. Mitrogianni Z, Barbouti A, Galaris D, Siamopoulos KC. Tyrosine nitration in plasma proteins from patients undergoing hemodialysis. Am J Kidney Dis. 2004;44:286-92.
45. Deng G, Vaziri ND, Jabbari B, Ni Z, Yan XX. Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition. J Am Soc Nephrol. 2001;12:1892-9.
46. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA. 1996;93:11853-8.
47. Sutherland WH, Gieseg SP, Walker RJ, de Jong SA, Firth CA, Scott N. Serum protein-bound 3,4-dihydroxyphenylalanine and related products of protein oxidation and chronic hemodialysis. Ren Fail. 2003;25:997-1009.
48. Molnar GA, Wagner Z, Marko L, Ko Szegi T, Mohas M, Kocsis B, Matus Z, Wagner L, Tamasko M, et al. Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production. Kidney Int. 2005;68:2281-7.